建立“促红细胞生成素（EPO）”系统。接受重组人促红细胞生成素治疗患者的管理。
Setting up an 'EPO' system. Management of patients receiving recombinant human erythropoietin.
作者信息
Brown S M
出版信息
Prof Nurse. 1992 Feb;7(5):282-3, 286-7.
PMID:1738775
Abstract
As more people with end stage renal disease are treated with erythropoietin for their anaemia, a well-coordinated system is essential to monitor their response to treatment. This is best achieved by keeping management of the system in the hands of one or two people.
摘要
随着越来越多的终末期肾病患者因贫血接受促红细胞生成素治疗，一个协调良好的系统对于监测他们的治疗反应至关重要。将系统管理交由一两个人负责是实现这一点的最佳方式。
Zotero 插件